Silencing of TBX20 gene expression in rat myocardial and human embryonic kidney cells leads to cell cycle arrest in G2 phase

Liu,Peiyan; Sun,Yueling; Qiu,Guangbin; Jiang,Hongkun; Qiu,Guangrong

doi:10.3892/mmr.2016.5660

Silencing of TBX20 gene expression in rat myocardial and human embryonic kidney cells leads to cell cycle arrest in G2 phase

Authors:
- Peiyan Liu
- Yueling Sun
- Guangbin Qiu
- Hongkun Jiang
- Guangrong Qiu
View Affiliations

Affiliations: Department of Medical Genetics, College of Basic Medical Science, China Medical University, Shenyang, Liaoning 110122, P.R. China, Department of Laboratory Medicine, 202 Hospital of People's Liberation Army, Shenyang, Heping 110003, P.R. China, Department of Pediatrics, The First Affiliated Hospital, China Medical University, Shenyang, Heping 110001, P.R. China
Published online on: August 19, 2016 https://doi.org/10.3892/mmr.2016.5660
Pages: 2904-2914
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Congenital heart diseases (CHDs) are the most common birth defects due to abnormal cardiac development. The T-box 20 (TBX20) gene is a member of the T‑box family of transcription factors and encodes TBX20, which is essential for early heart development. In the present study, reduced TBX20 expression was observed in CHD tissue samples compared with normal tissues, and the function of TBX20 in Rattus norvegicus myocardial cells [H9c2(2-1)] and human embryonic kidney cells (HEK293) was investigated. TBX20 was silenced in H9c2 and HEK293 cells via transfection of small interfering RNA and short hairpin RNA duplexes, respectively, and TBX20 mRNA and protein levels were subsequently examined using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis. Cell proliferation was assessed using a cell counting kit and proliferating cell nuclear antigen expression was determined by western blotting. Analysis of cell apoptosis was achieved by annexin V‑fluorescein isothiocyanate/propidium iodide staining and a fluorometric terminal deoxynucleotidyl transferase dUTP nick‑end labeling system. Cell cycle analysis was achieved using fluorescence‑activated cell sorting, and, an RT‑qPCR array was used to profile the expression of TBX20‑related genes. Silencing of TBX20 in H9c2 and HEK293 cells significantly inhibited cell proliferation, induced cell apoptosis and led to G2/M cell cycle arrest. A reduction in cyclin B1 mRNA levels and an increase in cyclin‑dependent kinase inhibitor 1B mRNA levels was observed, which indicated that cells were arrested in G2 phase. Concurrently, the mRNA levels of GATA binding protein 4 were increased in both cell lines, which may provide an explanation for the abnormal cardiac hypertrophy observed in patients with congenital heart disease. These results suggest that TBX20 is required for heart morphogenesis, and inhibition of TBX20 expression may lead to the suppression of cell proliferation and cell cycle arrest.

View Figures

View References

1	Hoffman JI and Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol. 39:1890–1900. 2002. View Article : Google Scholar : PubMed/NCBI
2	van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ and Roos-Hesselink JW: Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol. 58:2241–2247. 2011. View Article : Google Scholar : PubMed/NCBI
3	Thienpont B, Mertens L, de Ravel T, Eyskens B, Boshoff D, Maas N, Fryns JP, Gewillig M, Vermeesch JR and Devriendt K: Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J. 28:2778–2784. 2007. View Article : Google Scholar : PubMed/NCBI
4	Corrigan N, Brazil DP and McAuliffe F: Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol. 85:523–530. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gong LG, Qiu GR, Jiang H, Xu XY, Zhu HY and Sun KL: Analysis of single nucleotide polymorphisms and haplotypes in HOXC gene cluster within susceptible region 12q13 of simple congenital heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 22:497–501. 2005.PubMed/NCBI
6	Srivastava D: Making or breaking the heart: From lineage determination to morphogenesis. Cell. 126:1037–1048. 2006. View Article : Google Scholar : PubMed/NCBI
7	Cai CL, Zhou W, Yang L, Bu L, Qyang Y, Zhang X, Li X, Rosenfeld MG, Chen J and Evans S: T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development. 132:2475–2487. 2005. View Article : Google Scholar : PubMed/NCBI
8	Singh MK, Christoffels VM, Dias JM, Trowe MO, Petry M, Schuster-Gossler K, Bürger A, Ericson J and Kispert A: Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development. 132:2697–2707. 2005. View Article : Google Scholar : PubMed/NCBI
9	Stennard FA, Costa MW, Lai D, Biben C, Furtado MB, Solloway MJ, McCulley DJ, Leimena C, Preis JI, Dunwoodie SL, et al: Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development. 132:2451–2462. 2005. View Article : Google Scholar : PubMed/NCBI
10	Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi K, Heidt AB, Mori AD, Arruda EP, Gertsenstein M, Georges R, Davidson L, Mo R, et al: Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development. 132:2463–2474. 2005. View Article : Google Scholar : PubMed/NCBI
11	Qian L, Mohapatra B, Akasaka T, Liu J, Ocorr K, Towbin JA and Bodmer R: Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease. Proc Natl Acad Sci USA. 105:19833–19838. 2008. View Article : Google Scholar : PubMed/NCBI
12	Kirk EP, Sunde M, Costa MW, Rankin SA, Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, et al: Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291. 2007. View Article : Google Scholar : PubMed/NCBI
13	Liu C, Shen A, Li X, Jiao W, Zhang X and Li Z: T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease. Eur J Med Genet. 51:580–587. 2008. View Article : Google Scholar : PubMed/NCBI
14	Posch MG, Gramlich M, Sunde M, Schmitt KR, Lee SH, Richter S, Kersten A, Perrot A, Panek AN, Al Khatib IH, et al: A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet. 47:230–235. 2010. View Article : Google Scholar :
15	Pan Y, Geng R, Zhou N, Zheng GF, Zhao H, Wang J, Zhao CM, Qiu XB, Yang YQ and Liu XY: TBX20 loss-of-function mutation contributes to double outlet right ventricle. Int J Mol Med. 35:1058–1066. 2015.PubMed/NCBI
16	Chen J, Sun F, Fu J and Zhang H: Association of TBX20 gene polymorphism with congenital heart disease in Han Chinese neonates. Pediatr Cardiol. 36:737–742. 2015. View Article : Google Scholar
17	Shen T, Aneas I, Sakabe N, Dirschinger RJ, Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, et al: Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest. 121:4640–4654. 2011. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
19	Hammer S, Toenjes M, Lange M, Fischer JJ, Dunkel I, Mebus S, Grimm CH, Hetzer R, Berger F and Sperling S: Characterization of TBX20 in human hearts and its regulation by TFAP2. J Cell Biochem. 104:1022–1033. 2008. View Article : Google Scholar : PubMed/NCBI
20	Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, Stockbrügger RW and Blijham GH: Proliferating cell nuclear antigen (PCNA): A new marker to study human colonic cell proliferation. Gut. 35:530–535. 1994. View Article : Google Scholar : PubMed/NCBI
21	Stennard FA and Harvey RP: T-box transcription factors and their roles in regulatory hierarchies in the developing heart. Development. 132:4897–4910. 2005. View Article : Google Scholar : PubMed/NCBI
22	Chakraborty S and Yutzey KE: Tbx20 regulation of cardiac cell proliferation and lineage specialization during embryonic and fetal development in vivo. Dev Biol. 363:234–246. 2012. View Article : Google Scholar : PubMed/NCBI
23	Shelton EL and Yutzey KE: Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol. 302:376–388. 2007. View Article : Google Scholar
24	Tang L, Zhang Y, Pan H, Luo Q, Zhu XM, Dong MY, Leung PC, Sheng JZ and Huang HF: Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest and apoptosis in human endometrial cell. Reprod Biol Endocrinol. 7:1442009. View Article : Google Scholar
25	Paruthiyil S, Cvoro A, Tagliaferri M, Cohen I, Shtivelman E and Leitman DC: Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A and BTG2. Breast Cancer Res Treat. 129:777–784. 2011. View Article : Google Scholar
26	Yadav V, Sultana S, Yadav J and Saini N: Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PloS One. 7:e477962012. View Article : Google Scholar : PubMed/NCBI
27	Mitrea DM, Yoon MK, Ou L and Kriwacki RW: Disorder-function relationships for the cell cycle regulatory proteins p21 and p27. Biol Chem. 393:259–274. 2012. View Article : Google Scholar : PubMed/NCBI
28	Lee Y, Shioi T, Kasahara H, Jobe SM, Wiese RJ, Markham BE and Izumo S: The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol. 18:3120–3129. 1998. View Article : Google Scholar : PubMed/NCBI
29	Sepulveda JL, Vlahopoulos S, Iyer D, Belaguli N and Schwartz RJ: Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J Biol Chem. 277:25775–25782. 2002. View Article : Google Scholar : PubMed/NCBI
30	Vincentz JW, Barnes RM, Firulli BA, Conway SJ and Firulli AB: Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart development. Dev Dyn. 237:3809–3819. 2008. View Article : Google Scholar : PubMed/NCBI
31	Snyder M, Huang XY and Zhang JJ: Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells. J Biol Chem. 285:23639–23646. 2010. View Article : Google Scholar : PubMed/NCBI
32	Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I and Sperling SR: The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications and microRNAs. PLoS Genet. 7:e10013132011. View Article : Google Scholar
33	Chen Y and Cao X: NFAT directly regulates Nkx2-5 transcription during cardiac cell differentiation. Biol Cell. 101:335–349. 2009. View Article : Google Scholar
34	Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol. 317:614–619. 2008. View Article : Google Scholar : PubMed/NCBI
35	Pu WT, Ishiwata T, Juraszek AL, Ma Q and Izumo S: GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol. 275:235–244. 2004. View Article : Google Scholar : PubMed/NCBI
36	Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA and Molkentin JD: Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 98:837–845. 2006. View Article : Google Scholar : PubMed/NCBI
37	Guner-Ataman B, Paffett-Lugassy N, Adams MS, Nevis KR, Jahangiri L, Obregon P, Kikuchi K, Poss KD, Burns CE and Burns CG: Zebrafish second heart field development relies on progenitor specification in anterior lateral plate mesoderm and nkx2.5 function. Development. 140:1353–1363. 2013. View Article : Google Scholar : PubMed/NCBI
38	Zhao L, Ju D, Gao Q, Zheng X and Yang G: Over-expression of Nkx2.5 and/or cardiac α-actin inhibit the contraction ability of ADSCs-derived cardiomyocytes. Mol Biol Rep. 39:2585–2595. 2012. View Article : Google Scholar
39	Liu H, Harris TM, Kim HH and Childs G: Cardiac myocyte differentiation: The Nkx2.5 and Cripto target genes in P19 clone 6 cells. Funct Integr Genomics. 5:218–239. 2005. View Article : Google Scholar : PubMed/NCBI
40	Yamak A, Temsah R, Maharsy W, Caron S, Paradis P, Aries A and Nemer M: Cyclin D2 rescues size and function of GATA4 haplo-insufficient hearts. Am J Physiol Heart Circ Physiol. 303:H1057–H1066. 2012. View Article : Google Scholar : PubMed/NCBI
41	Laforest B and Nemer M: GATA5 interacts with GATA4 and GATA6 in outflow tract development. Dev Biol. 358:368–378. 2011. View Article : Google Scholar : PubMed/NCBI